Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Net Margin (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Net Margin for 5 consecutive years, with 4537.75% as the latest value for Q2 2025.

  • Quarterly Net Margin fell 83557.0% to 4537.75% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 8522.65% through Dec 2025, down 193128.0% year-over-year, with the annual reading at 1455.29% for FY2023, N/A changed from the prior year.
  • Net Margin hit 4537.75% in Q2 2025 for Kezar Life Sciences, down from 4771.18% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 8938.36% in Q4 2021 to a low of 330.04% in Q3 2023.
  • Historically, Net Margin has averaged 5327.83% across 5 years, with a median of 5682.8% in 2022.
  • Biggest five-year swings in Net Margin: soared 36266bps in 2023 and later tumbled -94045bps in 2024.
  • Year by year, Net Margin stood at 8938.36% in 2021, then tumbled by -33bps to 5951.1% in 2022, then tumbled by -106bps to 330.04% in 2023, then soared by 1728bps to 5373.32% in 2024, then dropped by -16bps to 4537.75% in 2025.
  • Business Quant data shows Net Margin for KZR at 4537.75% in Q2 2025, 4771.18% in Q1 2025, and 5373.32% in Q2 2024.